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Abstract
Salmonella enterica utilizes a type III secretion system (TTSS) encoded in its pathogenicity island 1 to mediate its initial
interactions with intestinal epithelial cells, which are characterized by the stimulation of actin cytoskeleton reorganization
and a profound reprogramming of gene expression. These responses result from the stimulation of Rho-family GTPases and
downstream signaling pathways by specific effector proteins delivered by this TTSS. We show here that AvrA, an effector
protein of this TTSS, specifically inhibits the Salmonella-induced activation of the JNK pathway through its interaction with
MKK7, although it does not interfere with the bacterial infection-induced NF-kB activation. We also show that AvrA is
phosphorylated at evolutionary conserved residues by a TTSS-effector-activated ERK pathway. This interplay between
effector proteins delivered by the same TTSS highlights the remarkable complexity of these systems.
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Introduction
Many bacteria that are pathogenic or symbiotic for plants,
insects or animals utilize type III protein secretion systems (TTSSs)
to modulate host-cellular functions through the activity of the
effector proteins that they deliver [1,2]. Salmonella enterica serovar
Typhimurium (S. Typhimurium), an enteropathogen that causes
inflammatory diarrhea, encodes two of such machines within its
pathogenicity islands 1 (SPI-1) and 2 (SPI-2) [3] [4]. The SPI-1
TTSS is required for this pathogen to enter and replicate within
intestinal epithelial cells [5]. In addition, this TTSS is required for
the stimulation of innate immune responses in intestinal epithelial
cells, which leads to inflammation and ultimately diarrhea [6,7].
These responses are specifically triggered by the SPI-1 TTSS
effector proteins, SopE, SopE2, and SopB, which activate Rho-
family GTPases in a functionally redundant fashion [8,9]. SopE
and SopE2 are guanine nucleotide exchange factors (GEFs) for
Rac, Cdc42, RhoA, and RhoG [10–12]. In contrast, SopB,
through its phosphoinositide phosphatase activity, activates RhoG
and Cdc42 by stimulating endogenous exchange factors for these
GTPases [8]. Activation of these GTPases leads to the stimulation
of NF-kB and the MAP kinases ERK, JNK, and p38 pathways,
which ultimately result in a profound transcriptional reprogram-
ming in epithelial cells closely resembling the responses that follow
the stimulation of innate immune receptors [6,9]. Therefore, the
initiation of the stimulation of intestinal inflammation by this
bacterium is dependent on specific bacterial adaptations rather
than the hard-wired generic responses to a pathogen mediated by
conserved innate immune receptors such as Toll-like (TLRs) or
nucleotide oligomerization domain (NLRs) receptors [13,14].
Indeed, the stimulation of inflammation is crucial for Salmonella’s
ability to grow in the intestinal tract, since essential nutrients do
not become available at this site unless such responses are
stimulated [15].
Activation of Rho-family GTPases and its downstream MAP
kinases or NF-kB signaling pathways can also result in significant
alteration of the host cell homeostasis that may be detrimental for
Salmonella’s ability to survive and replicate within these cells.
Therefore, Salmonella has evolved a mechanism to down-regulate
the responses triggered by its effector proteins. In a remarkable yin
and yang, S. Typhimurium delivers through the SPI-1 TTSS an
effector protein, SptP, which has GTPase-activating protein (GAP)
activity directed towards a subset of the GTPases activated by
SopE, SopE2 and SopB [16]. Thus, the activity of this bacterially-
encoded GAP ensures the rapid reversion of the cytoskeletal
changes induced by Salmonella infection.
AvrA is a SPI-1 TTSS effector protein that is a close homologue
of YopJ, a Yersinia spp. TTSS effector protein that inhibits the
activation of all MAP kinase kinases (MAP2Ks) and IkB kinases
(IKKs) by acetylating critical residues for activation [17–19]. It has
also been proposed that YopJ, and by extension AvrA, may have
deubiquitinase or desumoylase activities [20–22]. However, these
activities have been more recently brought into question and
therefore remain the subject of some controversy [23,24]. Despite
their close amino acid sequence similarity, which suggests similar
biochemical activity, AvrA does not phenocopy YopJ [25],
indicating that these two effector proteins do not exert the same
function and may target different cellular proteins. Although
transient overexpression studies have identified some potential
targets of AvrA [26,27], its role during cell infection is still poorly
understood. In this study, we present evidence that AvrA is
another example of a SPI-1 TTSS effector, which like SptP [16],
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effectors delivered by S. Typhimurium via the same TTSS. We
also report the identification of a naturally occurring allelic variant
of AvrA with impaired activity, suggesting that this effector may be
under strong evolutionary pressure to alter its function. In
addition, we show that AvrA is phosphorylated upon translocation
in an ERK-dependent manner, which may have implications for
the regulation of the function of this effector protein.
Results
Expression of AvrA in Saccharomyces cerevisiae revealed
an allelic variant with impaired function
Alignment of the annotated amino acid sequence of AvrA with
that of its close homologue YopJ of Yersinia showed a 14 amino
acid extension at the N-terminus of AvrA (Figure S1A). However,
a second potential initiation codon located at amino acid 15 of the
annotated open reading frame would generate an AvrA protein
whose predicted amino acid sequence is more similar in length to
YopJ. To ascertain which of these two putative initiation codons is
functional, we changed either ATG codon and examined the
expression of the resulting avrA mutants (Figure S1B). Mutation of
the first predicted ATG initiation codon to GCC had little effect
on the expression of AvrA in S. Typhimurium (Figure S1C). In
contrast, mutation of the second putative initiation codon to GCC
completely abolished avrA expression (Figure S1C). We concluded
from these results that the second initiation codon is the correct
translational start site and have therefore used for subsequent
studies the coding sequence derived from this codon (Figure S1D),
which differs from the originally annotated sequence.
It has been previously reported that in the yeast S. cerevisiae, the
AvrA homologue YopJ inhibits multiple MAP kinase pathways,
including the HOG pathway [28]. The HOG pathway in S.
cerevisiae most closely resembles the p38 pathway in mammals. We
tested whether AvrA would inhibit the HOG pathway when
expressed in the yeast S. cerevisiae by examining whether AvrA
inhibits yeast growth in high osmolarity conditions, since
adaptation to growth in high osmolarity media is dependent on
the HOG pathway [29]. In contrast to YopJ, expression of AvrA
in S. cerevisiae did not prevent growth in high osmolarity media
(Figure 1A). This result was surprising given the high degree of
amino acid sequence similarity between YopJ and AvrA. We
therefore examined the sequence of the avrA allele from the S.
Typhimurium strain SL1344 used in this experiment and found
that, in comparison to alleles from other strains of S. Typhimurium
such as LT2 [30], the SL1344 avrA allele has a three nucleotide
deletion resulting in the absence of a leucine residue at position
139 (Leu139) (Figure S2A). This change is not due to a sequencing
error since independently sequenced copies of avrA from SL1344
deposited in GenBank exhibit the same variation. Furthermore,
Author Summary
Salmonella Typhimurium is a major cause of diarrheal
disease worldwide. Central to S. Typhimurium’s pathogen-
esis is its ability to induce intestinal inflammation, which is
initiated by several bacterial proteins injected into
intestinal epithelial cells by a nanomachine known as the
type III secretion system. We show here that another
bacterial protein injected by this machine negatively
influences the responses triggered by Salmonella, presum-
ably to limit cellular damage. This interplay between
bacterial proteins of opposite function highlights the
remarkable complexity of the host/pathogen interface.
Figure 1. Expression of AvrA in S. cerevisiae inhibits the HOG
MAP kinase pathway at the level of MAP2K PBS2. A Expression
of the avrA allele from S. typhimurium LT2 strain, but not the allele from
the S. typhimurium SL1344 strain, inhibits yeast growth in high
osmolarity media. The yeast Saccharomyces cerevisiae strain NY605
(MATa, leu2-3,112, ura3-52, GAL+) carrying plasmids expressing the
indicated alleles of avrA or yopJ were spotted onto selective dextrose or
galactose plates containing 1 M sorbitol and the plates were then
incubated at 30uC for 2 days. B Expression of AvrA inhibits the
osmotically induced phosphorylation of the MAP kinase HOG1 of S.
cerevisiae HOG pathway. Lysates from S. cerevisiae expressing either
wild type AvrA or its catalytic mutant AvrA
C172S were analyzed by
western immunoblot with antibodies directed to phosphorylated p38,
and the HA and FLAG epitope tags (present in Hog1 and the AvrA
constructs, respectively). C Expression of AvrA suppresses the lethality
caused by constitutively active MAP3K mutants (SSK2DN and SSK22DN),
but not by constitutively active MAP2K mutant (PBS2DD). S. cerevisiae
strain NY605 expressing the indicated proteins were streaked onto
plates containing either dextrose or galactose (to induce expression of
the different avrA or yopJ constructs) and incubated at 30uC for 2 days.
doi:10.1371/journal.ppat.1000595.g001
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confirmed the presence of this allelic variation. Interestingly, this
allele is unique to SL1344 since all other sequenced alleles of AvrA
in the Genbank encode Leu139 (Figure S2B and data not shown).
Leu139 is located in a conserved region of this protein family
raising the possibility that this mutation may be functionally
significant. To investigate this hypothesis, we expressed in yeast an
avrA allele in which the three nucleotides (TTT) were inserted into
the SL1344-derived avrA after nucleotide 413 of the coding
sequence, thus creating an avrA allele identical to the one encoded
in the S. Typhimurium LT2 strain (AvrALT2). Expression of
avrALT2 inhibited yeast growth under high osmolarity conditions
(Figure 1A), and this inhibitory activity was strictly dependent on
the catalytic activity of AvrA since a catalytic mutant derivative
AvrALT2
C172A did not inhibit yeast growth (Figure 1A). Further-
more, similar to YopJ [28], this growth inhibition was due to
suppression of the HOG pathway by AvrALT2 , since overexpres-
sion of AvrALT2 inhibited phosphorylation of HOG1 without
altering its total protein level after high osmolarity stress
(Figure 1B). More specifically, overexpressed AvrALT2 exerted its
effect at the level of the MAP2K PBS2, since it was able to
suppress the lethal effects caused by overexpression of constitu-
tively active MAP kinase kinase kinases (MAP3Ks) SSK2 or
SSK22 mutants, but not by overexpression of the constitutively
active PBS2 mutant (Figure 1C). Taken together, these results
indicate that, like YopJ, AvrALT2 is capable of inhibiting MAP
kinase signaling in yeast and that the S. Typhimurium SL1344
strain harbors an allele incapable of exerting this activity. All
subsequent studies involving AvrA reported here were carried out
with the LT2 allele of AvrA (or mutant derivatives as indicated).
Transiently expressed or TTSS-delivered AvrA is
phosphorylated in mammalian cells
We noticed that when AvrA was expressed in S. Typhimurium
or E.coli, it migrates as a single band (Figure S1C). However, when
expressed in yeast, AvrA migrates as a triplet (Figures 1B and 2A).
We found that this mobility shift could be reversed by treatment
with the non-specific l phosphatase (data not shown), suggesting
Figure 2. AvrA is phosphorylated when expressed in S. cerevisiae or in mammalian cells. A AvrA is phosphorylated in S. cerevisiae. Extracts
of S. cerevisiae expressing the indicated FLAG epitope tagged alleles of AvrA or YopJ were analyzed by western immunoblot with antibodies directed
to the FLAG epitope. The lower panel shows longer exposure of the gel to visualize the dually phosphorylated form of AvrA (see text for details). B
Transiently expressed AvrA is phosphorylated in mammalian cells. COS cells were transfected with plasmid expressing FLAG epitope tagged AvrA,
YopJ, or their catalytic mutants AvrA
C172S and YopJ
C172S. Twenty-four hours after transfection, cell extracts were examined by western immunoblot
with an antibody directed to the FLAG epitope. C The mobility shift of transiently expressed AvrA is reversed after phosphatase treatment. COS cells
were transfected with plasmid expressing FLAG epitope tagged AvrA and twenty-four hours after transfection, cell extracts were treated with lambda
phosphatase in the presence or absence of a phosphatase inhibitor and examined by western immunoblot as indicated above. D AvrA is
phosphorylated and persists within mammalian cells after its delivery via the S. Typhimurium TTSS. Henle-407 cells were infected with a S.
Typhimurium strain expressing FLAG epitope-tagged AvrA and at the indicated times after infection, the presence of AvrA in the translocated and
bacteria-associated protein fractions was probed by western immunoblot with an anti FLAG antibody. The lower panels show a longer exposure of
the gel to visualize the dually phosphorylated form of AvrA. E Ser3 and Ser14 are essential for AvrA phosphorylation in mammalian cells. Henle-407
cells were infected with a S. Typhimurium strain expressing FLAG epitope-tagged AvrA or its mutant AvrA
S3C S14C and at the indicated times after
infection, the presence of AvrA in the translocated and bacteria-associated protein fractions was probed by western immunoblot with an anti FLAG
antibody. The lower panels show a longer exposure of the gel to visualize the dually phosphorylated form of AvrA.
doi:10.1371/journal.ppat.1000595.g002
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when expressed in yeast, YopJ migrated as a single band
(Figure 2A) indicating that it is not phosphorylated. Since AvrA
and YopJ differ significantly in their N-terminal 20 residues
(Figure S1D), we hypothesized that the sequences responsible for
AvrA phosphorylation were located within these amino acids.
Indeed, removal of the N-terminal 20 residues of AvrA abolished
its mobility shift (Figure S3A). There are several serine or
threonine residues within this region that could serve as potential
phosphorylation sites (Figure S3B), and mutagenesis analysis
indicated that Ser3 and Ser14 are essential for AvrA phosphor-
ylation in yeast (Figure S3C).
We tested whether AvrA could be phosphorylated in mamma-
lian cells, a more physiologically relevant model for S. Typhimur-
ium infection. Similar to what we observed in yeast, when
transiently expressed in mammalian cells and separated by SDS-
PAGE, AvrA, but not YopJ, migrated as a triplet (Figure 2B).
Treatment of the samples with the non-specific l phosphatase
eliminated the mobility shift (Figure 2C), demonstrating that
phosphorylation of AvrA was responsible for its mobility shift. Like
in yeast, mutations of Ser3 and Ser14 abolished the mobility shift
indicating that these residues are critical for phosphorylation
(Figure S3D).
We then tested whether AvrA was phosphorylated after its
delivery by the S. Typhimurium SPI-1 TTSS. Cultured intestinal
epithelial cells were infected with a strain of S. Typhimurium
expressing FLAG epitope tagged AvrALT2 or its derivatives
carrying mutations in Ser3 and Ser14 from its native promoter
in a low-copy plasmid, and the presence of AvrA in the
translocated protein fraction was analyzed over time. AvrA was
translocated into mammalian cells shortly after infection, and
remained detectable for several hours after infection (Figure 2D).
Furthermore, translocated AvrA exhibited a migration pattern in
SDS-PAGE consistent with its phosphorylation at both Ser3 and
Ser14 (Figure 2E). The mobility in SDS-PAGE of the translocated
epitope tagged AvrA
Ser3 or AvrA
Ser14 mutants confirmed that, like
in yeast, these two residues are essential for phosphorylation when
this effector is delivered during infection (Figure S3E). Interest-
ingly, both Ser3 and Ser14 are followed by a proline residue, and
these residues are highly conserved among AvrA alleles of different
Salmonella enterica serovars (Figure S2B), including the most distant
Salmonella enterica serovar S. Bongori (Figure S3F). Taken together,
these results indicate that shortly after delivery by the type III
secretion, AvrA is rapidly phosphorylated at two sites, and that
phosphorylated AvrA remains within the cell for an extended
period of time after infection.
The ERK pathway, which is activated upon S.
Typhimurium infection, is required for the
phosphorylation of AvrA in cultured intestinal epithelial
cells
The observation that both putative phosphorylation sites Ser3 and
Ser14 are followed by a proline residue suggests that a proline-
directed kinase(s) is responsible for their phosphorylation. Since MAP
kinases are themajor group of proline-directed kinases,wespecifically
tested whether AvrA is phosphorylated by MAP kinases. To identify
the MAP kinases involved in AvrA phosphorylation in mammalian
cells, we investigated the effect of specific MAP kinase inhibitors on
the SDS-PAGE migration pattern of translocated AvrA after
bacterial infection. Treatment of cells with JNK (SP600125) or p38
(SB203580) specific inhibitors had no measurable effect on the
migration pattern of translocated AvrA (Figure 3A), indicating that
these kinases are not involved in the phosphorylation of AvrA. In
contrast, translocated AvrA in cells treated with a specific MEK1/2
inhibitor (UO126) migrated largely as a single (unmodified) band,
implicating the ERK pathway in AvrA phosphorylation (Figure 3A).
Addition of any of these inhibitors had no effect on the levels of
translocated AvrA after infection (Figure 3A).
The observation that the ERK pathway was required for AvrA
phosphorylation was surprising since YopJ, a close homologue of
AvrA, was shown to inhibit all three MAP kinase pathways,
Figure 3. The ERK signaling pathway is required for AvrA
phosphorylation. A Effect of inhibitiors of MAP kinase pathways on
AvrA phosphorylation. Cultured Henle cells were incubated with 10 mM
each (alone or in combination) of the ERK (UO126), JNK (SP600125), or
p38 (SB203580) MAP kinase pathways 30 min prior to S. typhimurium
infection and were left throughout the experiment. Cells were infected
with a S. Typhimurium strain expressing C-terminally triple FLAG tagged
AvrA and at the indicated times after infection, the presence of AvrA
and activated ERK1/2 in the translocated protein fractions were probed
by western immunoblot with an anti FLAG or anti phospho-p44/42
MAPK antibodies respectively. The middle panel shows a longer
exposure of the gel to visualize the dually phosphorylated form of
AvrA. B S. Typhimurium DavrA strain expressing wild type AvrA or its
catalytic mutant AvrA
C172S activates ERK to similar levels. Henle-407
cells infected with the indicated S. Typhimurium strains for the
indicated times and cell lysates were probed by western immunoblot
with an anti FLAG or anti phospho-p44/42 MAPK antibodies
respectively. The middle panel shows a longer exposure of the gel to
visualize the dually phosphorylated form of AvrA. C AvrA interacts with
ERK2 but not MEK1 while YopJ interacts with MEK1 but not ERK2 in a
yeast two-hybrid assay. AvrA
C172S or YopJ
C172S were expressed in yeast
as baits along with the ERK pathway components as the targets as
indicated in the diagram. See Materials and Methods for details.
doi:10.1371/journal.ppat.1000595.g003
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AvrA was also able to inhibit the ERK pathway. As shown
previously [6], infection of mammalian cells with S. Typhimurium
resulted in rapid activation of the ERK pathway (Figure 3B).
However, infection with a strain expressing wild type or a catalytic
mutant of AvrA resulted in similar levels of ERK activation and
AvrA phosphorylation (Figure 3B). These results indicate that,
unlike YopJ, AvrA does not inhibit the ERK pathway when
translocated through the type III secretion system. This conclusion
is consistent with the finding that while YopJ interacted with
MEK1 in a yeast two-hybrid assay, AvrA did not (Figure 3C).
Instead, AvrA, but not YopJ, interacted with ERK2 in a yeast two-
hybrid assay (Figure 3C), suggesting that AvrA might be a direct
substrate of the proline-directed ERK1/2 kinase itself. These
results indicate that when delivered through the type III secretion
system, AvrA is phosphorylated by the Salmonella-activated ERK
pathway, and targets different signaling pathways than those
targeted by its homologue YopJ.
Delivery of AvrA through the SPI-1 type III secretion
system inhibits Salmonella-induced JNK pathway but not
the NF-kB pathway
Previous studies have shown that, like YopJ, transient overex-
pression of AvrA inhibited the NF-kB and JNK pathways [26,27].
We were able to confirm that overexpression of AvrA in cultured
mammalian cells resulted in the inhibition of TNFa-induced IL-8
promoter reporter stimulation, which is dependent NF-kB
(Figure 4A), as well as TNFa-stimulated JNK and p38 phosphor-
ylation (Figure 4B). We further demonstrated that overexpression of
AvrA inhibited the JNK and p38 pathways activated by S.
Typhimurium infection (Figure 4C). However, overexpression of
AvrA only slightly stabilized IkBa after Salmonella infection
(Figure 4C), suggesting that overexpressed AvrA may only inhibit
the NF-kB pathway very weakly. Consistent with this conclusion,
overexpressionof AvrA resulted in a very weak inhibition of the NF-
kB promoter reporter after addition of TNFa (Figure 4D).
Transient transfection experiments, however, lead to expression
levels of effector proteins that are usually orders of magnitude
higher than those achieved during bacterial infection. Non-
physiological levels of expression of an effector protein could
artificially alter its specificity and hence confound the interpreta-
tion of the results. Furthermore, during infection, AvrA operates in
conjunction with other effector proteins that have the capacity to
activate the specific pathways that could also be targeted by AvrA
itself. Consequently, the study of AvrA function without the
bacterial infection context could lead to misleading results. We
therefore tested the function of AvrA in the context of bacterial
infection of cultured mammalian cells. We found that contrary to
its effect in transient transfection experiments, AvrA had no effect
on the Salmonella infection-induced activation of the p38 or NF-kB
signaling pathways (Figure 4E). We observed the same level of
activation of these two signaling pathways whether cells were
infected with S. Typhimurium expressing active AvrA or an
isogenic DavrA mutant (Figure 4E). In contrast, JNK phosphory-
lation (a measure of its activation) was significantly inhibited in
cells infected with S. Typhimurium expressing active AvrA when
compared to cells infected with an isogenic DavrA mutant
(Figure 4E). This inhibition was specifically dependent on AvrA
since it could be complemented by introducing into the DavrA
mutant a plasmid encoding AvrA but not its catalytic mutant
(Figure 4E). These results indicate that AvrA translocated through
TTSS modulates the degree of activation of the Salmonella
infection-induced JNK signaling pathways.
Since AvrA translocated through TTSS inhibits Salmonella
infection-induced JNK pathway, but not the NF-kB pathway,
we further investigated whether AvrA modulated the qualitative
and/or quantitative output of the SPI-1-induced transcriptional
reprogramming stimulated by S. Typhimurium in cultured
intestinal epithelial cells. We infected cultured intestinal epithelial
cells with wild type, the isogenic DavrA mutant, or the isogenic type
III secretion-defective DinvA mutant, and compared their tran-
scriptional response profiles using DNA microarray analysis. The
list of genes that were upregulated after Salmonella infection was
very similar to what was found in previous microarray analyses
(Table S1) [9], indicating a high degree of reproducibility of this
assay. Interestingly, the induced expression levels of most genes,
many of which are known to be regulated by the NF-kB pathway,
were not affected by AvrA (Table S1). The expression of three
representative genes COX2, NFKBIA, and SOD2, which are
known to be regulated by NF-kB, were further analyzed using
quantitative RT-PCR (Figure 4F). No differences were detected
between their level of induction after infection with wild type or
the DavrA mutant strains. These results further support the
conclusion that AvrA translocated through TTSS does not affect
Salmonella infection-induced NF-kB pathway. However, the
expression of a small group of genes was stimulated to significantly
higher levels in cells infected with the S. Typhimurium DavrA
mutant than with the wild type (Table S1), suggesting that TTSS-
delivered AvrA inhibited their induction. Using quantitative RT-
PCR we confirmed this observation for JUN and FOSB, two of the
genes in this group. Interestingly, expression of JUN and FOSB
has been reported to be strongly dependent on the transcription
factor AP1, which in turn is activated by the JNK pathway [32].
Therefore the higher expression of these genes in cells infected
with the DavrA mutant is consistent with the observation that AvrA
inhibits the JNK pathway. Taken together, these results indicate
that AvrA can specifically influence the transcriptional output
stimulated by effectors of its SPI-1 TTSS during Salmonella
infection. In this context, the function of AvrA is conceptually
analogous to that of SptP, which also inhibits pathways initially
activated by Salmonella SPI-1 TTSS effectors. These two effectors,
AvrA and SptP, may even cooperate with each other since both
are capable of inhibiting Salmonella infection-induced JNK
activation albeit by different mechanisms [16]. These results also
underscore the pitfalls of transient overexpression experiments
since, in the case of AvrA, these experiments assigned some
phenotype to AvrA that was not observed when it was delivered by
Salmonella TTSS.
AvrA specifically interacts with MKK7
YopJ, the close homologue of AvrA, inhibits MAP kinase and
NF-kB pathways by specifically interacting with MKKs and IKKs,
and acetylating critical Ser and Thr residues [17–19]. Stimulation
of two MAP2Ks, MKK4 or MKK7, leads to JNK activation.
Howewer, MKK4 and MKK7 are not redundant since they are
activated by different stimuli and have different substrate specifity:
MKK7 is specific to the JNK pathway, while MKK4 can also
activate p38 pathway [33]. Transient overexpression of AvrA was
shown to inhibit MKK4 and MKK7-mediated JNK phosphory-
lation, and to acetylate MKK4 at Lys260 and Thr261 [26,27].
However, the effect of AvrA over these kinases when delivered
during bacterial infection by the SPI-TTSS, or the interactions
between MKK4, MKK7 and AvrA have not been reported. We
performed yeast two-hybrid assays with AvrA
C172S or YopJ
C172S
as baits, and components of the JNK and p38 pathways as targets.
We confirmed that YopJ
C172S interacted with all the MAP2Ks
tested (MKK3, MKK6, MKK4 and MKK7) (Figure 5A).
Inhibition of Signaling Pathways by AvrA
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typhimurium infection. A Transiently overexpressed AvrA inhibits TNFa-stimulated IL-8 transcription. HEK293 cells were co-transfected with a pIL8-
luc firefly luciferase reporter plasmid along with a plasmid encoding renilla luciferase (to standardize transfection), and when indicated, with a
plasmid encoding AvrA, YopJ or their catalytic mutants AvrA
C172S or YopJ
C172A. Twenty-four hours after transfection, cells were treated with TNFa
(10 ng/ml) for 30 min and the stimulation of IL-8 transcription in transfected cells was measured with the Dual-Luciferase Reporter Assay System
(Promega) as indicated in Materials and Methods. Values represent fold induction in cells transfected with the plasmid vector alone and are the
mean6standard deviation of three independent measurements. B and C Transiently overexpressed AvrA inhibits TNFa- and Salmonella infection-
stimulated JNK and p38 pathways. HEK293 cells were transfected with the indicated plasmids and 24 hs after transfection, cells were either treated
with TNFa (10 ng/ml) or infected with S. Typhimurium DavrA strain. Thirty minutes after treatment or at the indicated times after infection the
activation of p38 and JNK was assayed by western immunoblot using antibodies directed to the phosphorylated (activated) form of these kinases
(see Materials and Methods for details). D Transiently overexpressed AvrA inhibits TNFa-stimulated NF-kB promoter reporter transcription only very
weakly. The assay was performed in the same way as in A, except that the reporter plasmid pBIIX-Luc was used, which harbors two tandem repeats of
NF-kB recognition sites. Values represent fold induction in cells transfected with the plasmid vector alone and are the mean6standard deviation of
three independent measurements. E AvrA delivered by the S. Typhimurium TTSS inhibits the JNK signaling pathway but does not affect the p38 or
NF-kB pathways. HEK293 cells were infected with S. Typhimurium strains expressing AvrA or its catalytic mutant AvrA
C172S and at the indicated times
after infection, the stimulation of p38 and JNK, as well as stabilization of IkBa, were assayed by western immunoblot as described in Materials and
Methods. F Quantitative RT-PCR analysis of selected genes induced by S. typhimurium infection. Henle-407 intestinal epithelial cells were infected for
1 h with S. typhimurium wild type, DavrA or the type III secretion-defective DinvA strains, and then chased in DMEM supplemented with gentamicin
(100 mg/ml) for 3 hs. RT-qPCR was performed as described in Materials and Methods. COX2, NFKBIA, and SOD2 are regulated by the NF-kB pathway,
while JUN and FOSB are regulated by the JNK pathway. The threshold cycles for the specified genes were normalized against the reference gene
GAPDH. Values represent mRNA fold induction relative to that of DinvA strains and are the mean6standard deviation of four independent
measurements. **=P,0.001; *=P,0.05 (student t test, relative to wild type values).
doi:10.1371/journal.ppat.1000595.g004
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C172S only interacted with MKK7 (Figure 5A), the
only MAP2K that is specific to the JNK pathway. Phylogenetic
analysis revealed that MKK7 is most distant from the rest of
MAP2Ks (Figure 5B), and therefore may exhibit the most unique
structural features to be specifically targeted by AvrA. The specific
interaction between AvrA amd MKK7 is consistent with the
observed specific inhibition of the JNK pathway by AvrA when
delivered at physiological concentrations. Furthermore these
results indicate that AvrA, unlike YopJ, has evolved to narrow
its substrate to only one MAP2K.
Effect of phosphorylation on AvrA function
We next investigated the potential influence of AvrA phosphor-
ylation on its function when delivered by the S. Typhimurium SPI-
1 TTSS. Cultured intestinal epithelial cells were infected with S.
Typhimurium strains expressing the phosphorylation site mutants
AvrA
S3C, AvrA
S3D, AvrA
S14D, or AvrA
S14C from the AvrA native
promoter in a low-copy plasmid, and the levels of effector protein
translocation and JNK activation after infection were evaluated by
western immunoblot analysis over time. Cells infected with S.
Typhimurium expressing AvrA
S14D showed increased levels of
JNK activation in comparison to cells infected with a strain
expressing wild type AvrA or AvrA
S14C, despite similar levels of
protein translocation (Figure 6A). AvrA
S14D carries a mutation
that mimics the change in charge that results from its
Figure 5. AvrA specifically interacts with MKK7 in a yeast two-
hybrid assay. A AvrA
C172S or YopJ
C172S was expressed in yeast as a
bait along with the JNK or p38 pathway components as the targets as
indicated in the diagram. See Materials and Methods for details. B
Phylogenetic analysis of the human MKKs. The cladogram was
generated using ClustalW2 [42].
doi:10.1371/journal.ppat.1000595.g005
Figure 6. Effect of phosphorylation on AvrA function. A Effect of
phosphorylation on the ability of AvrA to inhibt S. Typhimurium-
activated JNK activation. Henle-407 cells were infected for 30 min with
a DavrA strain harboring a low copy plasmid expressing FLAG-epitope
tagged AvrA or the indicated mutants (all expressed from the avrA
native promoter), then chased in DMEM supplemented with gentamicin
(100 mg/ml) for the indicated times. The activation of JNK and the
phosphorylation of AvrA were monitored by western immunoblot
analysis as indicated above. B Effect of AvrA phosphorylaton on its
ability to inhibit S. Typhimurium-stimulated IL-8 transcription. HEK293
cells were co-transfected with pIL8-luc firefly luciferase reporter plasmid
along with a plasmid encoding renilla luciferase (to standardize
transfection). Twenty four hours after transfection, cells were infected
with S. Typhimurium strains expressing the indicated AvrA mutants and
the stimulation of IL-8 transcription in infected cells was measured with
the Dual-Luciferase Reporter Assay System (Promega) as indicated in
Materials and Methods. Values represent fold induction in cells
transfected with the plasmid vector alone and are the mean6standard
deviation of three independent measurements. **=P,0.001;
*=P,0.05 (student t test, relative to wild type values).
doi:10.1371/journal.ppat.1000595.g006
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of a phospho mimic mutation reduces AvrA activity and therefore
suggest that phosphorylation may have a negative effect on AvrA
function. Cells infected with S. Typhimurium expressing AvrA
S3D
also showed increased level of JNK phosphorylation relative to
cells infected with s strain expressing AvrA
S3C or wild type
(Figure 6A). However, this was probably due to reduced levels of
AvrA
S3D translocation (Figures 6A). In no case did the
phosphorylation mutants phenocopy the catalytic mutant Av-
rA
C172S (Figure 6A).
We also measured the effect of the phosphorylation site mutants
using a more quantitative IL-8 luciferase transcription reporter
system. In this assay, cells infected with S. Typhimurium
expressing wild type AvrA exhibited a reproducibly lower
(,50%) levels of IL-8 transcription reporter activity when
compared with cells infected with an isogenic DavrA strain
(Figure 6B). While cells infected with strains expressing AvrA
S3C
or AvrA
S14C show similar levels of IL-8 transcription reporter
activity as those infected with wild type, cells infected with strains
expressing the phosphomimic site mutants AvrA
S3D or AvrA
S14D
exhibited a slight but reproducibly higher level of IL-8
transcription reporter activity (Figure 6B). Taken together, these
results suggest that phosphorylation may have a negative effect on
AvrA activity.
Discussion
Salmonella Typhimurium has evolved a very complex functional
interface with its host, the product of evolutionary forces operating
over an extended time of coexistence. At the center of this
functional interface are two TTSSs, which work in concert to
modulate different aspects of Salmonella/host interactions [3,4].
One of these systems, encoded within the SPI-1, mediates the
initial interaction of S. Typhimurium with intestinal epithelial cells.
Although the function of only a subset of the proteins delivered by
this system is known, it is already evident that this system mediates
at least two very important aspects of Salmonella/host interactions:
1) entry and survival within intestinal epithelial cells; and 2)
stimulation of a profound transcriptional reprogramming in
intestinal epithelial cells that sets in motion an inflammatory
response. Both of these activities, which are dependent on the
ability of S. Typhimurium to activate members of the Rho-family
GTPases and the resulting activation of MAP kinase and NF-kB
signaling pathways, are crucial for Salmonella’s ability to replicate
within the host and spread to other hosts. In particular, the
stimulation of an inflammatory response is essential for Salmonella’s
ability to acquire scarce nutrients [15] and, through the
stimulation of diarrhea, to spread in the environment. However,
the stimulation of these responses does have potentially negative
effects. For example, potent stimulation of Rho-family GTPase
members may lead to programmed cell death [34], which may
result in the premature demise of cells actually ‘‘hosting’’ Salmonella
and serving as a ‘‘safe place’’ for their replication and survival.
Furthermore, a very strong inflammatory response may have
negative consequences on Salmonella’s long-term survival. Salmonella
has evolved mechanisms to limit these potentially harmful
responses. For example, Salmonella has evolved the ability to
specifically counter the activation of Rho-family GTPases. In a
remarkable yin and yang, Salmonella counters the function of the
SPI-1 effector proteins that activate Rho-family GTPases by
delivering through the same TTSS an effector protein with GAP
activity towards the GTPases activated by those effectors [16]. In
this study, we have presented evidence of another example of a
SPI-1 effector protein that counters the functional consequence of
the activities of other SPI-1 effector proteins. Indeed, we have
shown here that AvrA, through its catalytic activity, specifically
counters the SPI-1-TTSS effector protein activated JNK pathway,
thus modulating the transcriptional reprogramming that results
from this activation.
Previous studies using transient overexpression of AvrA have
reported that AvrA can also inhibit NF-kB signaling pathways
[26]. We have shown here that overexpression of AvrA inhibts
NF-kB signaling pathway only very weakly, but we have obtained
no evidence that S. Typhimurium inhibits NF-kB activation in
intestinal epithelial cells during bacterial infection. This is in
keeping with the profound pro-inflammatory nature of this
bacterium, and underscores the intrinsic difficulties of attempting
to glean the specific activity of an effector protein using
overexpression studies. Indeed, transient overexpression often
leads to protein levels orders of magnitude higher than the usually
very low levels reached by effector proteins after their delivery
through TTSSs. These much higher levels of a given effector
protein can lead to a loss of specificity and hence artifactual effects
on cellular physiology.
Our results are also in keeping with a previous report indicating
that S. Typhimurium can inhibit JNK pathway [27] and highlight
the significant differences between AvrA and its Yersinia spp.
homologue YopJ. While AvrA when delivered in physiological
amount has a rather narrow substrate specificity, inhibiting only
the JNK pathway, YopJ seems to have a much broader spectrum
of targets, inhibiting essentially all MAP kinase pathways as well as
NF-kB pathway [23,31]. Consistent with functional assays, yeast
two-hybrid assays revealed that AvrA only interacts with MKK7
while YopJ interacts with all the MAP2Ks tested. Therefore it
seems that evolution has tailored the activity of these highly related
proteins to suit the actual physiology of the bacteria that harbor
them. In the case of Yersinia spp., an extracellular pathogen, YopJ
has evolved to broadly inhibit the host innate immune response. In
contrast, the function of AvrA is more subtle and not aimed at
blocking the innate immune responses of intestinal cells but rather
at modulating them. This is consistent with the need for Salmonella
to induce inflammation to secure nutrients and spread to other
hosts [15]. The apparently rather narrow spectrum of targets for
AvrA activity which is directed to only the JNK pathway, is also in
keeping with the fact that AvrA itself is a target of the ERK
pathway, a MAP kinase pathway not targeted by this effector
protein. Although the role of phosphorylation on AvrA function is
still unclear, it is remarkable that the phosphorylation sites are
highly conserved across Salmonella serovars including the most
distantly related Salmonella Bongori. It is also intriguing that the
activity of AvrA may be modulated by a signaling pathway that is
stimulated by Salmonella infection.
Although clearly measurable, the phenotype of the DavrA
mutant is subtle in our in vitro assays. This is consistent with the
observation that in a mouse model of infection, absence of AvrA
results in no difference in the number of colony forming units
recovered from different tissues at different times after infection
when compared with wild type (unpublished observations). This
may mean that AvrA function is not critical in this specific animal
model of infection and/or that the in vitro assays used in this (and
other) studies are not adequate to probe its function. It is indeed
possible that AvrA may also target other signaling pathways in
addition to the JNK pathway. A deeper understanding of
Salmonella pathogenesis may be required to glean other potential
functions of AvrA.
We have reported here that the S. Typhimurium strain SL1344
encodes an AvrA allele with different functional properties from
those encoded by other S. Typhimurium strains. Although this allele
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remains possible that it retains activity against other, yet to be
identified, targets. In this context, it is interesting that some
Salmonella enterica serovars such as S. Typhi or S. Choleraesuis do not
encode avrA [17], and we have found that in some strains of S.
Typhimurium there are mutations within the avrA coding sequence
that render the protein non-functional in the assays utilized in these
studies (unpublished observations). It therefore appears that this
effector protein may be under selection pressure to alter its
specificity or, in some cases, to even completely lose its function.
In summary, we have shown here that AvrA specifically
modulates the output of signaling pathways triggered by S.
Typhimurium through the activity of SPI-1 effector proteins.
Along with SptP, AvrA is another example of an effector protein
whose activity is exerted in the context of the activities of other
effector proteins delivered by the same TTSS system. The
coordinated activity of TTSS effector proteins highlights the
remarkable complexity of these systems, which have been evolved
presumably to operate on both the pathogens and their hosts.
Materials and Methods
Plasmid constructs
The plasmids used in yeast growth assay were derived from
p416GAL1 [35]. The Open Reading Frames (ORFs) of AvrA,
YopJ or their variants were inserted between the Hind III and
Xho I sites downstream of the GAL1 promoter. Mutagenesis of
plasmids were performed with a QuikChange Site-Directed
Mutagenesis kit (Stratagene, CA). The plasmids pGSS21,
pGYC731 and pGPBD21 expressing GAL1-SSK2DN, GAL1-
SSK22DN and GAL1-PBS2(DD) respectively were kindly provid-
ed by Dr. Tatsuya Maeda (University of Tokyo, Tokyo, Japan).
The plasmid pIL-8-Luc has been described [8]. The AvrA
expressing plasmids used in mammalian cell transfections were
constructed by subcloning the ORFs encoding AvrA or their
derivatives into the HindIII and XhoI sites of pCDNA3.1
(Invitrogen). The YopJ expressing plasmids used in mammalian
cell transfections were constructed by subcloning the ORFs
encoding YopJ or their derivatives into the BamH I and Xba I
sites of the vector pRK5Flag. The plasmids used to express
proteins in S. Typhimurium were derived from pWKS130 [36].
The DNA fragments encoding C-terminally 3xFLAG tagged AvrA
or its mutants as well as the native AvrA promoter were cloned
into the Sac I and Kpn I sites of pWKS130. The details of plasmid
construction are available upon request.
Bacterial strains
All strains were derived from the S. enterica serovar Typhimur-
ium (S. Typhimurium) strain SL1344 [37]. The DavrA (SB1117)
[17] and DinvA (SB136) [38] mutants have been described
previously. The S. Typhimurium strains SB1432 and SB1434
were constructed by allelic exchange as previously described [39].
SB1432 encodes an avrA containing three additional nucleotides
(TTT) coding for a leucine at position 139 of the amino acid
sequence, which correspondes to the S. Typhimurium LT2 allele
of avrA. This strain was used as wild type in all these studies.
SB1434 is a derivative of SB1432 encoding a C-terminal 3xFLAG
tagged version of the modified AvrA. All bacterial strains were
cultured under conditions that stimulate the expression of the
Salmonella pathogenicity island-1–encoded TTSS [40]. Briefly,
overnight cultures were diluted 1:25 in L-broth containing 0.3 M
NaCl, incubated on a rotating wheel for 3 h at 37uC until an
optical density measured at 600 nanometers (OD600) of 0.9. The
cultures were then used immediately for infection.
Cell culture and bacterial infection
Henle-407 intestinal epithelial cells were routinely grown in 6-
well plates in DMEM supplemented with 10% bovine calf serum
(BCS; HyClone). Fifteen hours before infection, cells were washed
once with DMEM and incubated in DMEM overnight. Ten
minutes before infection, cells were washed once with pre-warmed
HBSS and incubated in 1 ml of HBSS at 37uC. Unless specified,
cells were infected with the indicated S. Typhimurium strains at an
MOI 30 for 1 h, and subsequently incubated in DMEM
supplemented with gentamicin (100 mg/ml) to kill extracellular
bacteria. Cells were then harvested at the indicated times and
samples were processed for Western blotting.
Yeast handling and growth assay
The yeast Saccharomyces cerevisiae strain NY605 (MATa, leu2-
3,112, ura3-52, GAL+) was transformed with various plasmids
according to standard protocol [41]. The transformants were
grown in selective yeast media containing 0.67% yeast nitrogen
base without amino acids, and proper auxotrophic amino acids at
the standard concentrations [41]. The carbon sources were either
2% glucose or 2% galactose, as indicated. Yeast transformants
were grown to an OD600,0.6, 1 ml of cells were then spun down
and resuspended into 1 ml of water. The samples were serially
diluted by 4-fold in a 96-well plate. The suspensions were then
spotted to plates containing selective SD or SGal media with 1 M
sorbitol using a 48-pin applicator. The plates were then incubated
at 30uC for 2 days. For experiments described in Figure 1C, the
yeast S. cerevisiae strain NY605 was transformed with two types of
plasmids. One type of plasmids expressed the constitutively active
MAP3K (SSK2DN and SSK22DN) or MAP2K (PBS2
DD), from
the galactose-inducible pGAL1 promoter. The other type of
plasmids expressed from a constitutive promoter pADH1 (or
pTEF) AvrA, YopJ, or their active site mutants AvrA
C172S or
YopJ
C172S. The transformants were re-streaked onto either
dextrose or galactose selective plates and incubated at 30uC for
2 days.
Extraction of proteins from yeast cells and
immunoblotting
The yeast transformants were grown in 2 mls of selective media
to an OD600 of 1.0. Cultures were mixed with equal volumes of
cold 40% TCA, spun down and resuspended into 300 mlo f1 6
SDS-PAGE sample buffer containing 100 mM DTT in a screw-
cap tube. Glass beads (,250 ml) were added to each tube and
yeast cells were broken open with mini-bead beater for 3 times,
1 min each time. The yeast extracts were then heated at 60uC for
5 min and cooled on ice. The debris were removed by
centrifugation at 14,000 rpm for 5 min, the pHs of the
supernatants were neutralized with 1 M Tris base, and then were
separated by SDS-PAGE. When indicated, the yeast transfor-
mants were also grown in selective liquid media containing the
non-inducing sugar raffinose until OD600,0.8, galactose was then
added to a final concentration of 2%, and 3 h later, 2 M NaCl
stock solution was added to a final concentration of 0.4 M. Five
and 10 min after this treatment, samples were taken and processed
for immunoblotting as described above.
Mammalian cell transfection and protein extraction
COS-2 and HEK293 cells were maintained in DMEM
(Invitrogen) supplemented with 10% heat-inactivated FCS (Gem-
ini). Plasmids were transfected into mammalian cells using
FuGENE 6 Transfection Reagents (Roche, IN) at the ratio of
3:1 (3 ul of FuGENE6 reagent for 1 mg of plasmid). Usually 1 mg
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Immediately before harvesting, cultured cells were rinsed with cold
HBSS, lysed in Extraction Buffer A (20 mM Tris-HCl [pH 7.5],
150 mM NaCl, 25 mM b-glycerophosphate, 0.5% NP40, 0.5 mM
DTT, 1 mM PMSF and 1 mM sodium orthovanadate), and
soluble cellular lysates analyzed by western immunoblotting.
Bacteriophage lambda phosphatase treatment of AvrA
COS-2 cells transfected with an AvrA-expressing plasmid were
lysed in lysis buffer (25 mM Tris-HCl [pH 7.6], 50 mM NaCl,
0.1% Triton X-100, 1 mM PMSF) at 4uC, cell lysates (80 mgo f
protein) were incubated with 400 U of lambda phosphatase (New
England Biolabs, MA ) at 30uC for 40 min, and the reaction was
then terminated by addition of SDS-containing loading buffer.
When indicated, 10 mM sodium orthovanadate was included as
an inhibitor of the lambda phosphatase.
Luciferase reporter assay
HEK293 cells were transfected with the reporter plasmid pIL8-
Luc, which encodes the firefly luciferase gene under the control of
IL8 promoter, along with a control plasmid (pRL-TK) encoding
renilla luciferase, and plasmids encoding either YopJ or AvrA.
24 h after transfection, cells were washed once with fresh DMEM,
and stimulated with TNFa (10 ng/ml) for 30 min in DMEM.
Cells were further incubated in fresh DMEM for another 5 h
before lysis in Cell Culture Lysis Reagent (Promega). Luciferase
activity was measured with the Dual-Luciferase Reporter Assay
System (Promega) using a luminometer following the recommen-
dations of the manufacturer All experiments were done in
triplicates. In some experiments, HEK293 cells were transfected
with the reporter plasmid pIL8-Luc and the control plasmid pRL-
TK, and 24 hs after transfection, cells were washed once with
fresh HBSS, and infected with different strains of S. Typhimurium
with a MOI of 10 for 30 min. Cells were then washed once with
pre-warmed DMEM, and incubated in DMEM supplemented
with gentamicin (100 g/ml) for another 5 hs to kill extracellular
bacteria. Cells were then lysed in Cell Culture Lysis Reagent
(Promega), and luciferase activities were measured as described
above. All experiments were done in triplicates.
Yeast two-hybrid analysis
The yeast two-hybrid analysis was performed using the
DupLEX-A Yeast Two-Hybrid System (OriGene Technologies)
following the instructions of the manufacturer. The DNA
fragments encoding AvrA
C172S or YopJ
C172S were cloned between
the EcoR I and Not I sites of the bait vector pEG202, and the
DNA fragments encoding MEK1, ERK2, ERK2
K52M, MKK3,
MKK6, p38a
K53M, MKK4, MKK7, and JNK1
K55M were cloned
between the SmaI and XhoI sites of the target vector pJG4-5. Both
the bait and target plasmids were co-transformed into the yeast
strain EGY48 and transformants were plated onto SD-HIS-TRP.
Yeast transformants were grown in selective media to an
OD600,0.6, 1 ml of cells were then spun down and its OD600
was adjusted to 1.0 with water. The samples were serially diluted
by 4-fold in a 96-well plate. The suspensions were then spotted
onto SD-HIS-TRP-LEU and SGAL-HIS-TRP-LEU plates. The
SD-HIS-TRP-LEU plates were incubated at 30uC for 2 days while
the SGAL-HIS-TRP-LEU plates were incubated at 30uC for 4
days.
Microarray gene expression profiling
Total RNA was isolated from the infected Henle-407 cells using
TRIzol reagent (Invitrogen) following the manufacturer’s protocol,
followed by on-column digestion of DNA using the RNeasy Mini
Kit (Qiagen). Samples were proceessed and hybridized to Human
Gene 1.0 ST Array (Affymetrix) at the Yale University W. M.
Keck facility. The data were analysed with NetAffx. Fold change
in gene expression were calculated for each S. typhimurium strain
relative to the type III secretion-defective S. Typhimurium DinvA
mutant strain.
Quantitative real-time PCR
Total RNA was isolated from infected Henle-407 cells using
TRIzol reagent (Invitrogen) following the manufacturer’s protocol,
followed by on-column digestion of DNA using the RNeasy Mini
Kit (Qiagen). Reverse transcription of RNA was performed using
iScript cDNA Synthesis Kit (Bio-Rad) following the manufactur-
er’s instructions. The cDNA mix was subject to RT-qPCR using
iQ SYBR Green Supermix (Bio-Rad). Reactions were run in an
iCycler real time PCR machine (Bio-Rad) and data were obtained
and analyzed using the iCycler iQ System (Bio-Rad). The
threshold cycles for the specified genes were normalized against
the reference gene GAPDH. RNA concentrations were measured
using Nanodrop ND-1000 Spectrophotometer (Nanodrop). The
gene-specific oligonucleotide pairs used for the qRT-PCR
reactions are as follows:
GAPDH: 59-GTCCACTGGCGTCTTCAC-39;5 9-CTTGAG-
GCTGTTGTCATACTTC-39
JUN 59: TGCCTCCAAGTGCCGAAAAA-39;5 9-TGACTT-
TCTGTTTAAGCTGTGCC-39
FOSB 59-TTTCCCCGGAGACTACGACTC-39;5 9-CTGG-
TTGTGATCGCGGTGA-39
COX2 59: ATATGTTCTCCTGCCTACTGGAA-39;5 9GC-
CCTTCACGTTATTGCAGATG-39.
NF-kB-IA: 59-CCGCACCTCCACTCCATCC-39;5 9-ACAT-
CAGCACCCAAGGACACC-39
SOD2 59: CTGCTGGGGATTGATGTGTGG-39;5 9-TGCA-
AGCCATGTATCTTTCAGT-39
IL-8 59: AGAGACAGCAGAGCACACAAG-39;5 9-AATCAG-
GAAGGCTGCCAAGAG-39
Supporting Information
Figure S1 (A) Nucleotide sequence surrounding the two putative
initiation codons of avrA as compared to that of yopJ. The putative
Shine-Dalgarno sequence of avrA is boxed. (B) A diagram showing
mutations of the two putative initiation codons (ATG) of avrA to
GCC. (C) AvrA is not expressed when the second putative
initiation codon is replaced by GCC. C-terminally M45 epitope
tagged AvrA or the mutants were expressed from its native
promoter in a low-copy plasmid in either S. typhimurium wild type
or a type III secretion-defective DinvG strains. The lysate was
probed by western immunoblot with an anti M45 antibody. (D)
Amino acid sequence alignment of AvrALT2 and YopJ. The active
sites are denoted with an arrow and the residue Leu139 that is
missing in S. typhimurium SL1344 strain is boxed.
Found at: doi:10.1371/journal.ppat.1000595.s001 (4.59 MB TIF)
Figure S2 (A) Alignment of nucleotide sequences from avrA and
yopJ surrounding the three nucleotides (TTT) that are missing in S.
typhimurium SL1344 strain. (B) Variations of amino acid sequence
of AvrA from several Salmonella enterica serovars. Leu139 is missing
only in the S. typhimurium SL1344 strain.
Found at: doi:10.1371/journal.ppat.1000595.s002 (2.03 MB TIF)
Figure S3 Identification of Ser3 and Ser14 of AvrA as the
phosphorylation sites in yeast and mammalian cells. (A) AvrA
lacking its first 20 amino acids is not phosphorylated in S. cerevisiae.
Inhibition of Signaling Pathways by AvrA
PLoS Pathogens | www.plospathogens.org 10 September 2009 | Volume 5 | Issue 9 | e1000595Extracts of S. cerevisiae expressing the indicated FLAG epitope
tagged alleles of AvrA were analyzed by western immunoblot with
antibodies directed to the FLAG epitope. The lower panel shows
longer exposure of the gel. (B) Amino acid sequence alignment of
the N-terminal 20 residues of AvrA and YopJ. Identical residues
are boxed and the two stretches of Ser/Thr residues of AvrA are
underlined. (C) Ser3 and Ser14 are essential for AvrA phosphor-
ylation in yeast. Extracts of S. cerevisiae expressing the indicated
FLAG epitope tagged alleles of AvrA were analyzed by western
immunoblot with antibodies directed to the FLAG epitope. The
lower panel shows longer exposure of the gel to visualize the dually
phosphorylated form of AvrA. (D) Ser3 and Ser14 are essential for
AvrA phosphorylation in mammalian cells after transfection. COS
cells were transfected with plasmid expressing the indicated FLAG
epitope tagged AvrA mutants and twenty four hours after
transfection, cell extracts were analyzed by western immunoblot
as indicated above. The lower panel shows a longer exposure of
the gel to visualize the dually phosphorylated form of AvrA. (E)
Ser3 and Ser14 are essential for AvrA phosphorylation in
mammalian cells after delivery by the TTSS. Henle-407 cells
were infected with a S. Typhimurium strain expressing FLAG
epitope-tagged AvrA or its mutant AvrA
S3C, AvrA
S3D, AvrA
S14C,
or AvrA
S14D. At the indicated times after infection, the presence of
AvrA in the translocated protein fractions was probed by western
immunoblot with an anti FLAG antibody. The lower panels show
a longer exposure of the gel to visualize the dually phosphorylated
form of AvrA. (F) Amino acid sequence alignment of the N-
terminal 20 residues of AvrALT2 and AvrABongori. The two
phosphorylation sites Ser3 and Ser14 as well as their following Pro
residues are conserved. The identical residues are boxed.
Found at: doi:10.1371/journal.ppat.1000595.s003 (3.67 MB TIF)
Table S1 Microarray analysis of the transcriptional responses
induced by different strains of Salmonella Typhimurium.
Found at: doi:10.1371/journal.ppat.1000595.s004 (0.05 MB PDF)
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